Share on StockTwits

Medidata Solutions (NASDAQ:MDSO) President Vries Glen Michael De unloaded 20,000 shares of the company’s stock in a transaction dated Tuesday, June 17th. The stock was sold at an average price of $40.26, for a total value of $805,200.00. Following the transaction, the president now directly owns 991,603 shares of the company’s stock, valued at approximately $39,921,937. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shares of Medidata Solutions (NASDAQ:MDSO) traded up 0.61% on Thursday, hitting $42.96. The stock had a trading volume of 613,509 shares. Medidata Solutions has a 52-week low of $32.10 and a 52-week high of $68.21. The stock’s 50-day moving average is $38.0 and its 200-day moving average is $52.75. The company has a market cap of $2.246 billion and a price-to-earnings ratio of 244.00.

Medidata Solutions (NASDAQ:MDSO) last announced its earnings results on Tuesday, April 22nd. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by $0.05. The company had revenue of $76.60 million for the quarter, compared to the consensus estimate of $79.50 million. During the same quarter in the previous year, the company posted $0.18 earnings per share. The company’s revenue for the quarter was up 21.0% on a year-over-year basis. Analysts expect that Medidata Solutions will post $0.75 EPS for the current fiscal year.

MDSO has been the subject of a number of recent research reports. Analysts at Topeka Capital Markets raised their price target on shares of Medidata Solutions to $49.00 in a research note on Wednesday. Separately, analysts at Stifel initiated coverage on shares of Medidata Solutions in a research note on Tuesday. They set a “buy” rating and a $47.00 price target on the stock. Finally, analysts at Stifel Nicolaus initiated coverage on shares of Medidata Solutions in a research note on Tuesday. They set a “buy” rating and a $47.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $56.57.

Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.